Abstract
Peroxisomal disorders are a heterogeneous group of diseases caused by mutations in a large number of genes. One of the genetic disorders known to cause this situation is ACBD5 (Acyl-CoA binding-domain-containing-5) gene mutations that have been described in recent years. Here, we report two siblings with a novel homozygous nonsense variation (c.1297C>T, p.Arg433*) in ACBD5 (NM_145698.4) gene using Clinical Exome Sequencing (Sophia Genetics).
Acknowledgement
We would like to thank Dr Sacha Ferdinandusse, the valuable lecturer of the Amsterdam UMC institution, for her contributions.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. Aubourg, P, Wanders, R. Peroxisomal disorders. Handb Clin Neurol 2013;113:1593–609, https://doi.org/10.1016/b978-0-444-59565-2.00028-9.Search in Google Scholar PubMed
2. Steinberg, SJ, Dodt, G, Raymond, GV, Braverman, NE, Moser, AB, Moser, HW. Peroxisome biogenesis disorders. Biochim Biophys Acta 2006;1763:1733–48, https://doi.org/10.1016/j.bbamcr.2006.09.010.Search in Google Scholar PubMed
3. Buchert, R, Tawamie, H, Smith, C, Uebe, S, Innes, AM, Al Hallak, B, et al.. A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA Reductase 1 deficiency. Am J Hum Genet 2014;95:602–10, https://doi.org/10.1016/j.ajhg.2014.10.003.Search in Google Scholar PubMed PubMed Central
4. Monte, MJ, Alonso, M, Briz, O, Herraez, E, Macias, RIR, Perez, MJ, et al.. Identification of a new inborn error in the peroxisomal steps of bile acid synthesis resulting in accumulation of toxic bile acid intermediates and hepatocellular damage. J Hepatol 2016;64:S301, https://doi.org/10.1016/s0168-8278(16)00388-3.Search in Google Scholar
5. Abu-Safieh, L, Alrashed, M, Anazi, S, Alkuraya, H, Khan, AO, Al-Owain, M, et al.. Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes. Genome Res 2013;23:236–47, https://doi.org/10.1101/gr.144105.112.Search in Google Scholar PubMed PubMed Central
6. Ferdinandusse, S, Falkenberg, KD, Koster, J, Mooyer, PA, Jones, R, van Roermund, CWT, et al.. ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism. J Med Genet 2017;54:330–7, https://doi.org/10.1136/jmedgenet-2016-104132.Search in Google Scholar PubMed
7. Cohen Simonsen, A, Bernchou Jensen, U, Faergeman, NJ, Knudsen, J, Mouritsen, OG. Acyl-coenzyme A organises laterally in membranes and is recognised specifically by acyl-coenzyme A binding protein. FEBS Lett 2003;552:253–8, https://doi.org/10.1016/s0014-5793(03)00970-0.Search in Google Scholar PubMed
8. Yagita, Y, Shinohara, K, Abe, Y, Nakagawa, K, Al-Owain, M, Alkuraya, FS, et al.. Deficiency of a retinal dystrophy protein, acyl-CoA binding domain-containing 5 (ACBD5), impairs peroxisomal beta-oxidation of very-long-chain fatty acids. J Biol Chem 2017;292:691–705, https://doi.org/10.1074/jbc.m116.760090.Search in Google Scholar
9. Islinger, M, Voelkl, A, Fahimi, HD, Schrader, M. The peroxisome: an update on mysteries 2.0. Histochem Cell Biol 2018;150:443–71, https://doi.org/10.1007/s00418-018-1722-5.Search in Google Scholar PubMed PubMed Central
10. van Roermund, CW, Visser, WF, Ijlst, L, van Cruchten, A, Boek, M, Kulik, W, et al.. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J 2008;22:4201–8, https://doi.org/10.1096/fj.08-110866.Search in Google Scholar PubMed
11. Fan, J, Liu, J, Culty, M, Papadopoulos, V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 2010;49:218–34, https://doi.org/10.1016/j.plipres.2009.12.003.Search in Google Scholar PubMed PubMed Central
12. Kikuchi, M, Hatano, N, Yokota, S, Shimozawa, N, Imanaka, T, Taniguchi, H. Proteomic analysis of rat liver peroxisome: presence of peroxisome-specific isozyme of Lon protease. J Biol Chem 2004;279:421–8, https://doi.org/10.1074/jbc.m305623200.Search in Google Scholar PubMed
13. Waterham, HR, Ferdinandusse, S, Wanders, RJ. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta 2016;1863:922–33, https://doi.org/10.1016/j.bbamcr.2015.11.015.Search in Google Scholar PubMed
14. Volpe, JJ, Adams, RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 1972;20:175–98, https://doi.org/10.1007/bf00686900.Search in Google Scholar
15. Kelley, RI, Datta, NS, Dobyns, WB, Hajra, AK, Moser, AB, Noetzel, MJ, et al.. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet 1986;23:869–901, https://doi.org/10.1002/ajmg.1320230404.Search in Google Scholar PubMed
16. Powers, JM, Liu, Y, Moser, AB, Moser, HW. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992;51:630–43, https://doi.org/10.1097/00005072-199211000-00007.Search in Google Scholar PubMed
17. van der Knaap, MS, Valk, J. Magnetic resonance of myelination and myelin disorders, 3th ed. Berlin: Springer; 2005.10.1007/3-540-27660-2Search in Google Scholar
18. Poll-The, BT, Gartner, J. Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 2012;1822:1421–9, https://doi.org/10.1016/j.bbadis.2012.03.011.Search in Google Scholar PubMed
19. Nash, BM, Wright, DC, Grigg, JR, Bennetts, B, Jamieson, RV. Retinal dystrophies, genomic applications in diagnosis and prospects for therapy. Transl Pediatr 2015;4:139–63, https://doi.org/10.3978/j.issn.2224-4336.2015.04.03.Search in Google Scholar PubMed PubMed Central
20. Werdich, XQ, Place, EM, Pierce, EA. Systemic diseases associated with retinal dystrophies. Semin Ophthalmol 2014;29:319–28, https://doi.org/10.3109/08820538.2014.959202.Search in Google Scholar PubMed
21. Michelakakis, HM, Zafeiriou, DI, Moraitou, MS, Gootjes, J, Wanders, RJA. PEX1 deficiency presenting as Leber congenital amaurosis. Pediatr Neurol 2004;31:146–9, https://doi.org/10.1016/j.pediatrneurol.2004.01.013.Search in Google Scholar PubMed
22. Majewski, J, Wang, Z, Lopez, I, Al Humaid, S, Ren, H, Racine, J, et al.. A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing. J Med Genet 2011;48:593–6, https://doi.org/10.1136/jmedgenet-2011-100288.Search in Google Scholar PubMed
23. Weleber, RG, Tongue, AC, Kennaway, NG, Budden, SS, Buist, NR. Ophthalmic manifestations of infantile phytanic acid storage disease. Arch Ophthalmol 1984;102:1317–21, https://doi.org/10.1001/archopht.1984.01040031067026.Search in Google Scholar PubMed
24. Cohen, SM, Green, WR, de la Cruz, ZC, Brown, FR3rd, Moser, HW, Luckenbach, MW, et al.. Ocular histopathologic studies of neonatal and childhood adrenoleukodystrophy. Am J Ophthalmol 1983;95:82–96, https://doi.org/10.1016/0002-9394(83)90336-7.Search in Google Scholar PubMed
© 2021 Walter de Gruyter GmbH, Berlin/Boston
